Molecular events in neuroendocrine prostate cancer development

Nature Reviews Urology, Published online: 21 July 2021; doi:10.1038/s41585-021-00490-0Neuroendocrine prostate cancer predominantly develops from adenocarcinoma following a period of androgen suppressive treatment. Outcomes in patients with this disease are poor; the understanding of the molecular mechanisms behind its development will improve future targeted therapy options.

Source: Nature Reviews Urology - July 21, 2021 Category: Urology & Nephrology Authors: Yong Wang Yu Wang Xinpei Ci Stephen Y. C. Choi Francesco Crea Dong Lin Yuzhuo Wang Source Type: research